Medikit Co

Medikit Co ROA

The Return on Assets (ROA) of Medikit Co (7749.T) as of Nov 3, 2026 is 5.64 %. In the previous year, Return on Assets (ROA) was 5.74 % — a change of -1.75% (lower).

ROA

5.64 %

YoY

-1.75%

Last updated:

In 2026, Medikit Co's return on assets (ROA) was 5.64 %, a -1.75% increase from the 5.74 % ROA in the previous year.

The Medikit Co ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2019
5.56 JPY
Jan 1, 2020
5.88 JPY
Jan 1, 2021
5.32 JPY
Jan 1, 2022
5.86 JPY
Jan 1, 2023
5.39 JPY
Jan 1, 2024
6.02 JPY
Jan 1, 2025
5.74 JPY
Jan 1, 2026
5.64 JPY
The Medikit Co ROA history
YEARROAYoY
5.64 %-1.75%
5.74 %-4.57%
6.02 %+11.75%
5.39 %-8.04%
5.86 %+10.06%
5.32 %-9.56%
5.88 %+5.83%
5.56 %+0.04%
5.56 %+2.28%
5.43 %-5.11%
5.73 %-0.19%
5.74 %+16.37%
4.93 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Medikit Co Stock analysis

What does Medikit Co do? The history of the company Medikit Co Ltd dates back to the 1970s, when the company was founded as a small family business in Japan. Over time, Medikit grew into a multinational company with offices in Asia, Europe, and North America. Medikit's business model is focused on developing, manufacturing, and selling innovative medical devices and consumables. The company specializes in three areas: Medical Instruments, Medical Consumables, and Medical Technology. In the field of Medical Instruments, Medikit offers a wide range of products for use in diagnosis and therapy. These include endoscopes for examining hollow organs such as the stomach and intestines, as well as flexible endoscopes for examining bronchi and lungs. In addition, the range includes ultrasound devices for diagnosing heart, blood vessel, and musculoskeletal disorders, as well as surgical instruments for use in minimally invasive surgery. In the field of Medical Consumables, Medikit offers bandages, injection and infusion sets, catheters and urinary drainage systems, as well as blood collection systems. Products for home care, such as ostomy care and incontinence supplies, are also part of the portfolio. In the field of Medical Technology, Medikit offers technologies for telemedicine and hospital routine. These include systems for wireless transmission of vital parameters such as blood pressure and heart rate, as well as data storage and processing systems for medical examination data. Medikit is constantly striving to improve its products and offer customers the best products. This has resulted in Medikit having one of the best research and development departments in medical technology. Research is conducted, among other things, on better diagnostic procedures and new surgical methods. Another important aspect of Medikit's business model is to work closely with medical facilities and professionals to better understand the needs of customers and offer them customized solutions. This is also reflected in the numerous trainings and workshops that Medikit offers for medical professionals. Overall, Medikit Co Ltd has established itself as a reliable and innovative provider in medical technology. By combining top-notch products with excellent service, the company demonstrates that it stands by its customers in every situation. Medikit Co is one of the most popular companies on Eulerpool.

ROA Details

Understanding Medikit Co's Return on Assets (ROA)

Medikit Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Medikit Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Medikit Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Medikit Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Medikit Co stock

Return on Assets (ROA) of Medikit Co is 5.64 % in 2026.

Return on Assets (ROA) of Medikit Co changed from 5.74 % to 5.64 %, representing a -1.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Medikit Co since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Medikit Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Medikit Co

All Key Metrics — Medikit Co